You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, T-Cell, Cutaneous

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EBV Lymphomas, EBV-associated Malignancies Trial (EBV-specific T-cells)

Withdrawn
  • EBV Lymphomas
  • EBV-associated Malignancies
  • EBV-specific T-cells
  • (no location specified)
Jun 9, 2020

Anal Cancer Squamous Cell Trial in São Paulo (prebiotics in combination with probiotics)

Recruiting
  • Anal Cancer Squamous Cell
  • prebiotics in combination with probiotics
  • São Paulo, SP, Brazil
    AC Camargo Cancer Center
Jan 13, 2023

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
Has Results
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Tissue Collection Protocol for Gastroesophageal Cancers

Recruiting
  • Esophageal Cancer
  • Tissue Collection
  • Toronto, Ontario, Canada
    University Health Network: Toronto General Hospital
Apr 8, 2022

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

Not yet recruiting
  • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
  • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +175 more
Jul 24, 2019

Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in Scottsdale, Jacksonville, Rochester (Everolimus)

Completed
Has Results
  • Leukemia
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Oct 11, 2019

Opioid Use Disorder, Sleep Disturbance Trial in Birmingham (Post-Illumination Pupillary Response (PIPR), Polysomnography,

Not yet recruiting
  • Opioid Use Disorder
  • Sleep Disturbance
  • Post-Illumination Pupillary Response (PIPR)
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 24, 2023

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Advanced Cancers Trial in Houston (Temsirolimus, Metformin)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Multiple Myeloma Trial in Canada (Isatuximab)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • Edmonton, Alberta, Canada
  • +9 more
Feb 14, 2022

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

Chronic Myocardial Ischemia Trial in France (Autologous MSC from bone marrow, Placebo comparator)

Recruiting
  • Chronic Myocardial Ischemia
  • Autologous MSC from bone marrow
  • Placebo comparator
  • Créteil, France
  • +5 more
Oct 27, 2021

Implants, Cochlear, Child, Hearing Loss, Bilateral Trial in Iowa City (Hybrid L24)

Completed
  • Implants, Cochlear
  • +2 more
  • Hybrid L24
  • Iowa City, Iowa
  • +1 more
Nov 3, 2022

Eczema, Psoriasis Trial in Singapore (Photoacoustic imaging and Confocal Raman spectroscopy measurement)

Recruiting
  • Eczema
  • Psoriasis
  • Photoacoustic imaging and Confocal Raman spectroscopy measurement
  • Singapore, Singapore
    National Skin Centre
Sep 27, 2022

Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells

Completed
  • Hepatocellular Carcinoma
  • +3 more
  • ET1402L1-ARTEMIS™ T cells -IV
  • +2 more
  • Xi'an, China
    The First Affiliated Hospital of Xi'an Jiaotong University
Mar 26, 2021

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial (F520)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • (no location specified)
Oct 19, 2020

Patients With Restenosis of Calcified Lesions

Recruiting
  • Coronary Artery Calcification
  • +3 more
  • Coronary artery calcification lesions
  • Shenyang, Liaoning, China
    ShenyangNH
Jul 14, 2022

Squamous Cell Carcinoma Trial in Baltimore (Bavituximab, Pembrolizumab)

Recruiting
  • Squamous Cell Carcinoma
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 17, 2022

Colorectal Liver Metastases Trial in Amsterdam, Leiden (Irreversible electroporation (IRE))

Completed
  • Colorectal Liver Metastases
  • Irreversible electroporation (IRE)
  • Amsterdam, Noord-Holland, Netherlands
  • +2 more
Dec 18, 2022

Core Biomarkers of Alzheimer's Disease

Recruiting
  • Alzheimer's Disease
    • Beijing, Beijing, China
      Xuanwu Hospital of Capital Medical University
    Aug 18, 2021

    ctDNA Methylation for Detecting Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • +8 more
    • Methylation assay
    • Beijing, Beijing, China
      Lei Li
    Mar 24, 2023

    Diabetes Complications, Cardiovascular Diseases Trial in Portland (Mediterranean Diet)

    Recruiting
    • Diabetes Complications
    • Cardiovascular Diseases
    • Mediterranean Diet
    • Portland, Maine
      Maine Medical Center
    Jan 9, 2022

    Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Taipei (Nivolumab)

    Recruiting
    • Locally Advanced Esophageal Squamous Cell Carcinoma
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 22, 2021